GlassScriptPhysician profile
Kimberly Havens
NPI 1336713965
$1,714.05
in general payments reported to CMS, 2019-2025
19 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.07 · 2022: $356 · 2023: $334 · 2024: $505 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,265.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $364.39 | 2022-2025 | Jynarque, Voyxact |
| Astrazeneca Pharmaceuticals LP | $315.48 | 2022-2025 | Farxiga, Lokelma |
| Mallinckrodt Hospital Products INC. | $209.67 | 2022-2025 | Acthar |
| Aurinia Pharma U.S., INC. | $95.23 | 2022-2024 | Lupkynis |
| Ani Pharmaceuticals, INC. | $93.45 | 2022-2024 | Purified Cortrophin Gel |
| Abbvie INC. | $92.07 | 2021 | |
| Vifor Pharma, INC. | $72.14 | 2023-2024 | Veltassa |
| Novartis Pharmaceuticals Corporation | $59.27 | 2023-2025 | |
| Calliditas Therapeutics US INC. | $58.98 | 2025 | Tarpeyo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.84 | 2024-2025 | Jardiance |
| Ardelyx, INC. | $49.68 | 2024 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $46.71 | 2022-2024 | |
| Renalytix Ai, INC. | $41.10 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Amgen INC. | $36.34 | 2023-2025 | Krystexxa, Tavneos |
| Fresenius USA Marketing, INC. | $32.22 | 2024 | Velphoro |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $32.01 | 2025 | Ozempic |
| Medtronic, INC. | $23.69 | 2022 | |
| Genzyme Corporation | $21.96 | 2025 | |
| Vantive US Healthcare LLC | $17.82 | 2025 | Renal - Pd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Havens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.